home / stock / cdxc / cdxc quote
Last: | $2.775 |
---|---|
Change Percent: | -1.09% |
Open: | $2.79 |
Close: | $2.775 |
High: | $2.84 |
Low: | $2.74 |
Volume: | 166,959 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.775 | $2.79 | $2.775 | $2.84 | $2.74 | 166,959 | 07-19-2024 |
$2.76 | $2.9 | $2.76 | $2.96 | $2.74 | 282,553 | 07-18-2024 |
$2.91 | $3.02 | $2.91 | $3.02 | $2.85 | 346,332 | 07-17-2024 |
$3.07 | $2.79 | $3.07 | $3.105 | $2.79 | 515,088 | 07-16-2024 |
$2.77 | $2.74 | $2.77 | $2.865 | $2.6801 | 359,413 | 07-15-2024 |
$2.61 | $2.9 | $2.61 | $3.08 | $2.52 | 708,914 | 07-12-2024 |
$2.88 | $2.65 | $2.88 | $2.92 | $2.65 | 331,566 | 07-11-2024 |
$2.63 | $2.6 | $2.63 | $2.67 | $2.56 | 146,594 | 07-10-2024 |
$2.63 | $2.54 | $2.63 | $2.66 | $2.48 | 371,304 | 07-09-2024 |
$2.51 | $2.57 | $2.51 | $2.62 | $2.405 | 360,275 | 07-08-2024 |
$2.51 | $2.494 | $2.51 | $2.55 | $2.4414 | 253,679 | 07-05-2024 |
$2.54 | $2.57 | $2.54 | $2.62 | $2.5 | 133,145 | 07-04-2024 |
$2.54 | $2.57 | $2.54 | $2.62 | $2.5 | 133,145 | 07-03-2024 |
$2.58 | $2.68 | $2.58 | $2.71 | $2.55 | 234,013 | 07-02-2024 |
$2.69 | $2.77 | $2.69 | $2.7899 | $2.61 | 387,694 | 07-01-2024 |
$2.73 | $2.64 | $2.73 | $2.8 | $2.57 | 6,312,544 | 06-28-2024 |
$2.65 | $2.64 | $2.65 | $2.85 | $2.52 | 472,372 | 06-27-2024 |
$2.67 | $2.43 | $2.67 | $2.69 | $2.305 | 398,054 | 06-26-2024 |
$2.44 | $2.5 | $2.44 | $2.68 | $2.42 | 427,137 | 06-25-2024 |
$2.55 | $2.75 | $2.55 | $2.8673 | $2.55 | 328,374 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
ChromaDex Corporation Company Name:
CDXC Stock Symbol:
NASDAQ Market:
ChromaDex Corporation Website:
U.S. FDA-registered 503B outsourcing facility, Wells Pharma of Houston, will compound and distribute Niagen (nicotinamide riboside chloride) IV and injections to Cenegenics, Clean Market/NutriDrip, Drip Hydration, EXTEN IV, Kensho Wellbeing, The NAD MD, Next Health, The Remedy Room, Restore Hyper...
ChromaDex continues to drive innovation and growth with its proprietary Tru Niagen ® supplement, backed by strong financial performance and a robust intellectual property portfolio ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD +...
NR improved the six-minute walking distance and treadmill walking time for those with PAD ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD + ) research, shares results from a milestone phase II clinical study showcasing the promising effe...